KPRX: Kiora Pharmaceuticals, Inc. Amount of Cash per Share

Corporate emblem and logo of Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals relies on a compact staff of geneticists motivated by stock options. The efficiency of such personnel, combined with streamlined climate-controlled supply chains, is evident in the cash per share trend, where the current level is 3.71. This trend confirms the company's financial stability, which, given the shortage of therapies for rare retinal pathologies, guarantees high demand across ophthalmology centers.

KPRX (kiorapharma.com) Cash per Share history from 07/04/2022 to 11/20/2026

Analytical breakdowns for Kiora Pharmaceuticals

- market capitalization information:
- cash position and cash flow details:
Comprehensive company analysis:KPRX Kiora Pharmaceuticals, Inc.
Core merchandise of Kiora Pharmaceuticals

This indicator reflects the amount of free cash flow per common share. The calculation is based on the daily ratio of liquid flow to the total number of securities. The stability of cash per share amid geopolitical fragmentation confirms that Kiora Pharmaceuticals (KPRX) maintains a financial reserve. However, excessive capital conservation limits the development of ophthalmological research during equipment supply disruptions. While such a strategy ensures survival, it reduces long-term profitability.